The chemokine interleukin‐8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia

We have identified differentially regulated genes in chronic myeloid leukemia (CML) cells upon short treatment with the broad‐spectrum Bcr–Abl inhibitor dasatinib. The highly specific Bcr–Abl inhibitor nilotinib caused a very similar gene expression signature, validating the identified differentiall...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Hantschel, Oliver, Gstoettenbauer, Agnes, Colinge, Jacques, Kaupe, Ines, Bilban, Martin, Burkard, Thomas R., Valent, Peter, Superti-Furga, Giulio
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2008
Assuntos:
Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527809/
https://ncbi.nlm.nih.gov/pubmed/19383348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2008.07.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados